Results
Senores Pharmaceuticals Q1 Revenue Up 36% YoY
Senores Pharmaceuticals reported unaudited Q1 FY27 results with consolidated revenue growth of 35.9% YoY to ₹180.2 crores.
EBITDA grew by 87% YoY with margin expansion of approximately 800 basis point
